Oramed Pharmaceuticals Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    €0.00 -100.0% -€16.35M -445.8% N/A -€7.19M -16.4% N/A
    €1.15M -50.4% €4.73M -114.6% 412.3% +18 pp -€8.60M -63.4% -749.3% +2.7 pp
    €2.31M +0.0% -€32.33M +69.8% -1,397.1% -5.7 pp -€23.48M +31.8% -1,014.5% -2.4 pp
    €2.31M -0.3% -€19.04M +93.2% -822.7% -4.0 pp -€17.81M +68.4% -769.7% -3.1 pp
    €2.32M +0.3% -€9.85M -19.8% -424.8% +1.1 pp -€10.58M -4.4% -456.0% +0.22 pp
    €2.31M +10.4% -€12.29M +12.8% -531.1% -0.11 pp -€11.06M -11.8% -478.2% +1.2 pp
    €2.10M -0.3% -€10.90M +21.4% -519.7% -0.93 pp -€12.54M +151.6% -598.3% -3.6 pp
    €2.10M +283.2% -€8.97M -4.4% -426.7% +13 pp -€4.99M -224.9% -237.1% -9.6 pp
    €548.75K +∞% -€9.39M +51.6% -1,710.5% -17 pp €3.99M -194.3% 727.6% +7.3 pp
    €0.00 +NaN% -€6.19M +27.0% N/A -€4.23M +22.0% N/A
    €0.00 +NaN% -€4.88M +34.6% N/A -€3.47M +19.6% N/A
    €0.00 -100.0% -€3.62M +26.5% N/A -€2.90M +47.4% N/A
    €157.74K -6.7% -€2.86M +114.2% -1,815.1% -10 pp -€1.97M +38.2% -1,248.0% -4.1 pp
    €169.00K +∞% -€1.34M -47.6% -790.9% -7.9 pp -€1.42M +17.9% -842.8% -8.4 pp
    €0.00 +NaN% -€2.55M +7.9% N/A -€1.21M -37.6% N/A
    €0.00 +NaN% -€2.36M -0.3% N/A -€1.94M +31.1% N/A
    €0.00 +NaN% -€2.37M -14.4% N/A -€1.48M +183.2% N/A
    €0.00 +NaN% -€2.77M +680.6% N/A -€521.36K +68.4% N/A
    €0.00 +NaN% -€354.91K +805.6% N/A -€309.57K +794.3% N/A
    €0.00 +NaN% -€39.19K -93.6% N/A -€34.62K -86.1% N/A
    €0.00 +NaN% -€616.39K +1,340.0% N/A -€248.27K +625.0% N/A
    €0.00 -€42.80K N/A -€34.24K N/A

    Notifications